Pages that link to "Q34231837"
Jump to navigation
Jump to search
The following pages link to Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor (Q34231837):
Displaying 50 items.
- Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies (Q26745527) (← links)
- How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? (Q26748867) (← links)
- Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues (Q26750671) (← links)
- Fetal Microchimerism in Cancer Protection and Promotion: Current Understanding in Dogs and the Implications for Human Health (Q27025003) (← links)
- Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments (Q28067102) (← links)
- Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies (Q33777096) (← links)
- Maternal-fetal cellular trafficking: clinical implications and consequences (Q33838736) (← links)
- Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies (Q33856960) (← links)
- Naturally acquired microchimerism (Q33921152) (← links)
- Haploidentical transplantation: the search for the best donor (Q34019548) (← links)
- Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection (Q34352679) (← links)
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. (Q34398420) (← links)
- Long-term feto-maternal microchimerism revisited: Microchimerism and tolerance in hematopoietic stem cell transplantation (Q34558107) (← links)
- The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age. (Q35041195) (← links)
- Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission (Q35181654) (← links)
- MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells (Q35201839) (← links)
- Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation (Q35786957) (← links)
- Microchimerism in cord blood: mother as anticancer drug (Q35787149) (← links)
- HLA-targeted cell sorting of microchimeric cells opens the way to phenotypical and functional characterization (Q35877017) (← links)
- Alterations in maternal-fetal cellular trafficking after fetal surgery (Q36041489) (← links)
- Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members (Q36109429) (← links)
- Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance (Q36235327) (← links)
- Increased maternal microchimerism after open fetal surgery (Q36535733) (← links)
- Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application (Q36605814) (← links)
- Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications (Q36746512) (← links)
- Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning (Q36902123) (← links)
- Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting (Q37271276) (← links)
- Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation (Q37323408) (← links)
- Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation (Q37396289) (← links)
- Mother and child T cell receptor repertoires: deep profiling study. (Q37413084) (← links)
- Overview of the progress on haploidentical hematopoietic transplantation (Q37522577) (← links)
- Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses (Q37524719) (← links)
- Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias (Q37576040) (← links)
- Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer. (Q37590606) (← links)
- A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies (Q37694704) (← links)
- The great debate: haploidentical or cord blood transplant (Q37806066) (← links)
- Relapsing Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation (Q37858169) (← links)
- Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation (Q37906064) (← links)
- At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies (Q38149725) (← links)
- Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers (Q38190856) (← links)
- Human NK cells: from surface receptors to the therapy of leukemias and solid tumors (Q38196803) (← links)
- Experts' considerations on HLA-haploidentical stem cell transplantation (Q38198728) (← links)
- Haploidentical stem cell transplantation for the treatment of leukemia: current status (Q38248521) (← links)
- Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias. (Q38569646) (← links)
- Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency (Q38904894) (← links)
- T cell depleted haploidentical transplantation: positive selection. (Q38912466) (← links)
- BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation (Q38922475) (← links)
- Can we make a better match or mismatch with KIR genotyping? (Q39027714) (← links)
- Markers and function of human NK cells in normal and pathological conditions (Q39068084) (← links)
- Minor histocompatibility antigen UTY as target for graft-versus-leukemia and graft-versus-haematopoiesis in the canine model (Q39249452) (← links)